Description

▪ Introduction

Clenoxin 60 by Proton Pharma contains Clenbuterol Hydrochloride (HCL) 60 mcg per tablet, a pharmaceutical-grade β2-adrenergic agonist developed for licensed respiratory care and laboratory applications. It is studied for its bronchodilatory properties, particularly in relation to bronchospastic disorders such as asthma and COPD.

Manufactured to GMP-certified standards, Clenoxin 60 offers high purity and accurate dosing, making it suitable for respiratory research and regulated institutional use. Proton Pharma ensures precision in formulation for licensed B2B distribution only.

▪ Product Details (Bulleted)

• Active Ingredient: Clenbuterol Hydrochloride (HCL)

• Dosage Strength: 60 mcg per tablet

• Form: Oral tablets

• Brand: Proton Pharma

• Package Size: 60 tablets per pack

• Intended Use: Laboratory, clinical, and analytical use (licensed B2B only)

▪ Pharmacokinetics

Clenbuterol HCL exhibits a long half-life of approximately 36–48 hours with high oral bioavailability. Its onset begins within 30 minutes, with bronchodilatory effects lasting up to 12 hours. The compound acts on β2-adrenergic receptors to promote smooth muscle relaxation in the airways, making it useful in studies involving respiratory modulation.

▪ Usage Recommendations

• Typical Experimental Use: As outlined in respiratory research protocols under licensed oversight

• Administration Route: Oral

• Use Statement: For use in licensed laboratory and analytical settings. Not intended for consumer use.

▪ Disclaimer

This product is intended exclusively for licensed B2B distribution and laboratory or clinical use. Not approved for over-the-counter sale, personal consumption, or non-regulated applications. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with contraindicated medical conditions. Use must comply with all local regulations and institutional protocols.